Ramiven 200 mg Tablet
  1. Home
  2. Pharma Products
  3. Eli Lilly and Company India Pvt Ltd
  4. Ramiven 200 mg Tablet

Ramiven 200 mg Tablet

Ramiven 200 mg Tablet contains abemaciclib 200 mg, a targeted anticancer medicine used for certain hormone receptor-positive, HER2-negative breast cancers. It is an oral prescription tablet taken according to the treatment plan prescribed by the oncologist. Abemaciclib works by inhibiting CDK4 and CDK6 proteins involved in cancer-cell growth and division.

BUY NOW

Category

Ramiven 200 mg Tablet is used for certain adults with HR-positive, HER2-negative early, locally advanced, or metastatic breast cancer, depending on the treatment setting. Abemaciclib is a cyclin-dependent kinase 4/6 inhibitor that helps slow the progression of cancer cells by blocking cell-cycle signaling. The dose and duration are determined by the oncologist based on the treatment regimen, disease status, and patient response. Ramiven 200 mg is marketed in India by Eli Lilly and Company India Pvt Ltd and is listed in a 14-tablet pack.

Technical Specification

Specification Details
Active Ingredient Abemaciclib
Strength 200 mg
Dosage Form Film-Coated Tablet
Route of Administration Oral
Pack Size 14 Tablets
Manufacturer/Marketer Eli Lilly and Company India Pvt Ltd

Product Also Known As

Ramiven 200 mg Tablet, Ramiven 200 Tablet, Ramiven Abemaciclib 200 mg, Abemaciclib 200 mg Tablet, Abemaciclib Breast Cancer Tablet, Abemaciclib CDK4/6 Inhibitor Tablet

Related products